Kindbody has named David Stern as Chief Executive Officer, bringing three decades of fertility industry experience to lead the national fertility clinic network’s next growth phase. The company operates 27 signature clinics and IVF laboratories, maintains partnerships with over 400 clinics, and serves patients in 113 countries worldwide.
Stern joins Kindbody from Boston IVF, where he served as CEO for five years leading one of the largest fertility networks in the United States. His appointment comes as the New York-based company, founded in 2018, continues expanding its dual model as both a clinic operator and employer benefits provider serving more than 135 companies.
“David’s unparalleled leadership and three decades of expertise in women’s health uniquely position him to lead Kindbody into a bold new era of growth and innovation,” said Linda Mintz, Chairperson of Kindbody’s Board. “As reproductive healthcare takes center stage in the national conversation, there has never been a more exciting moment to expand Kindbody’s impact and empower more patients on their family-building journeys.”
Stern’s career spans multiple senior executive roles across fertility and women’s health companies. As CEO of Symbiomix Therapeutics, he led the company through development and commercial launch of Solosec, culminating in its acquisition by Lupin Pharmaceuticals in 2017. He previously held leadership positions at Merck Serono as Senior Vice President and Head of the Global Fertility Business Franchise, and at EMD Serono as Executive Vice President of Endocrinology.
His experience also includes strategic roles at Celmatix, Ohana, and OvaScience, where he focused on building commercial teams and expanding scientific partnerships. Stern holds an MBA from Babson College’s F.W. Olin Graduate School of Business and a Bachelor of Science in Biology from Brandeis University.
“I am truly honored to join a company that has set the standard for innovation and leadership in reproductive healthcare,” said Stern. “Kindbody’s commitment to patient-centered care and its trailblazing model—as the only family-building benefits provider for employers that also operates its own network of clinics—is transforming the way people access fertility services.”
Kindbody distinguishes itself as a fertility benefits provider that serves patients directly through its own clinic network, creating an integrated experience spanning fertility assessments, preservation, genetic testing, IVF, donor and surrogacy services, adoption, postpartum care, and menopause support.
Kindbody has raised more than $315 million in debt and equity funding from investors including Perceptive Advisors, JP Morgan Chase’s Morgan Health, GV, RRE Ventures, and Claritas Health Ventures.
